Skip to content

Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements

Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements A Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07017062
Enrollment
44
Registered
2025-06-12
Start date
2025-06-30
Completion date
2027-01-31
Last updated
2025-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occlusal Wear of Teeth

Brief summary

This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).

Interventions

OTHERhybrid ceramic occlusal veneers

occlusal veneers cemented with self adhesive resin cements

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Age ≥ 21 years * Vital teeth * Sufficient tooth structure for veneer retention * Willing and able to provide written informed consent * Ability to attend all follow-up appointments * Adequate oral hygiene as determined by the investigator

Exclusion criteria

* • Patients with active periodontal disease (probing depth \> 4mm, bleeding on probing) * Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination) * Poor oral hygiene (plaque index \> 30%) * Pregnancy or nursing * Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression) * Known allergies to study materials (ceramic, or resin cement components) * Inability to comply with study requirements * Current participation in other dental clinical trials * Active orthodontic treatment

Design outcomes

Primary

MeasureTime frameDescription
Marginal discoloration18 monthsMeasuring device: Modified USPHS criteria Alpha: No discoloration on margin Bravo: Discoloration found at margin Charlie: Discoloration with penetration in a pulpal direction

Secondary

MeasureTime frameDescription
Retention18 monthsMeasuring device: Modified USPHS criteria Alpha: retained Charlie: debonded
Marginal adaptation18 monthsMeasuring device: Modified USPHS criteria Alpha: explorer does not catch or has one way catch when drawn across restoration/tooth interface Bravo: explorer falls into crevice when drawn across the restoration tooth interface Charlie: Dentin or base exposed along margin
Postoperative hypersensitivity18 monthsMeasuring device: Modified USPHS criteria Alpha: Absent Charlie: Present
Recurrent caries18 monthsMeasuring device: Modified USPHS criteria Alpha: no evidence of caries at the margin of restoration Charlie: evidence of caries continuous with the margin of restoration

Countries

Egypt

Contacts

Primary ContactHayat Ibrahim El Banna, Lecturer
hayat.elbanna@dentistry.cu.edu.eg00201001248734

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026